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ABSTRACT

This research work is composed of two projects: namely,
chemical synthesis of 3-hydroxykynurenine glucoside, an important
lens

metabolite

and;

examining,

with

the

aid

of

capillary

electrophoresis and electrospray mass spectrometry, the serine loss
of the C-terminal extensions of bovine aA and pB2 lens crystallins in
order to determine whether any age related degradation occurs.
3-Hydroxykynurenine

glucoside

is

a compound

present in

human lens. The function of this chemical is as yet unknown,
however, it is possible that it may play a role as a UV filter
compound

preventing

damage

to

the

lens.

The

hydroxykynurenine glucoside has been restricted

study

of

3-

by the limited

amount of this compound that can be obtained from lenses. In this
project, the synthesis aims to supply sufficient compound in order to
make more further detailed study of 3-hydroxykynurenine glucoside
possible.
Both

capillary

electrophoresis

and

electrospray

mass

spectrometry are new analytical techniques which came into general
use in the 90's. This project utilises the high resolution and accuracy
of these methods to confirm a serine loss from C-terminal extensions
of aA and pB2 crystallins with ageing. The C-terminal extensions of
a A and PB2 crystallins consist of 8 (a A) and 11 (pB2) amino acid

residues, and they may play a major role in the formation of lens
crystallin aggregations. This arrangement of the crystallin is crucial
to the maintenance of lens transparency and its disruption can lead
to opacification of the lens (Carver et al.y 1992). Recent work has
found the terminal extensions have great flexibility compared with
the bulk of the protein making them digestible by enzymes present
in the lens. Confirmation of a serine loss from aA and |3B2 crystallins
and that this serine loss occurs at the C-terminal extensions. This
suggests the presence of a carboxypeptidase A like enzyme in the
lens digests these proteins throughout life.
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CHAPTER 1
GENERAL INTRODUCTION

1.1. The

eye and

lens

Fig. 1 Diagrammatic section through the eye.
Fig.

1 shows the structure of the eye. The light which is

transm itted
humour,
During

by

lens
this

the
and

process,

eye

passes

vitreous
the

body,

lens,

through
before

which

aqueous body by zonular ligaments,

the

cornea,

reaching

is suspended

aqueous

the

retina.

between

the

filters, transmits and focuses

the light onto the retina. Fig. 2 shows the unique structure of the
lens.

Some

special

properties

are associated

with

this

structure.

For example, in the lens the newly formed younger cells crowd
around older cells, as a result of this, there is no cell loss from the
lens, leading to lens growth throughout life. Another property of

2
the lens is the absence of cell nuclei, DNA and RNA, hence the lens’
cell metabolic pathways differ markedly from normal tissue cells,
particularly

with respect

to protein renewal.

Consequently,

there

are a number of different types of post-translational modifications
to lens proteins associated

with both aging of the lens and the

onset of diseases such as cataract (Harding, 1991).

ipithelium

Cortex

Anterior

Equato

Fig. 2. Diagrammatic section through the lens.

1.2

3 -H y d ro x y kyn u ren i n e

w eight

com pound

in

In the primate
been

identified

glucoside,
HPLC

and

as

the

lens,

hum an

analysis methods (Fig.
glucoside

1973;

kynurenine

glucoside,

fluorescence,

was

Wood

first

low

m o le c u la r

lens

3-hy d ro x y k y n u ren in e ,

Heyningen,

A

three low molecular compounds

L -kynurenine

hydroxykynurenine

g lu c o sid e :

using

have

3 - h y d ro x y k y n u r e n in e

protein-free

extraction

and

3). Of these three compounds,
represents
and

the

major

species

3-

(van

T ru s c o tt,

1993).

3 -H y d r o x y

which

g ive s

stro n g

b lu e - w h i t e

separated

from

a
the

human

lens

by

Heyningen (1971a). The separation used paper electrophoresis

van

3

Indole Amine
Dioxygenase

Tryptophan

H NH 2
COOH
H H
N— CHO
H

Formamidase

L-N'-Formylkynurenine

COOH

Kynurenine
3-monooxygenase
h

nh2

COOH

3-hydroxykynurenine

h

H

Conjugation with Glucose

NHOH

GLUCOSE

3-Hydroxykynurenine
Glucoside

3-Hydroxyanthranilic
Acid (30HA)
u11

-\

MH>2
COOH

Alanine
SCHEME 1. The 3-hydroxykynurenine glucoside
pathway of tryptophan metabolism

4
and the compound was identified by cleaving the glucoside using
hydrolysis with ß-glucosidase or 1 M hydrochloric acid to give 3hydroxykynurenine

and

D-glucose

(van

Heyningen,

1971a,

b).

Later this ß-glucosidase hydrolysis experiment was repeated by
Brando et al. (1981) and 3-hydroxykynurenine and glucose were
identified by amino acid analysis and gas chromatography (GC)
resp ectiv ely .

Fig. 3 HPLC chromatogram of the protein-free extract of the human lens. The
detecting wavelength is 365 nm. The numbers above the peaks are retention times in
minutes. The compounds were shown to be 3-hydroxykynurenine (14.7 min), 3-

5

hydroxy-kynurenine glucoside (17.1 min) and kynurenine (29.7 min). This fig. is
reproduced from Wood and Truscott (1993).
1.3

3-H ydroxykynurenine

of

glucoside:

a

m etabolic

product

tryp top h an

Scheme 1 shows the major metabolic pathway of tryptophan
in mammals. In step 1, the indole ring of tryptophan is cleaved. In
the liver, this step is catalysed by an inducible enzyme, indole
amine

dioxygenase,

which

forms

L-N'-formylkynurenine.

(Feigekson and Greengard, 1961). The same product is formed in
other

organs

(Hayaishi,

by

the

enzyme

indoleamine-2,3-dioxygenase

1971). The N’-formylkynurenine is hydrolysed by

formamidase in step 2 to give kynurenine (Knox and Mehler,
1950). In step 3, the enzyme kynurenine 3-monooxygenase is
responsible for the hydroxylation of kynurenine at position 3
(Okamoto et al. 1967). In step 4, 3-hydroxykynurenine is cleaved
by

kynureninase

to

3-hydroxyanthranilic

acid

and

alanine

(Hayaishi and Okamoto, 1971). In step 5, a lens specific reaction is
shown, in which 3-hydroxykynurenine is conjugated with glucose
to form 3-hydroxykynurenine glucoside. The mechanism of this
reaction is not yet clear. Until now, only two glucosides have been
found

in

mammalian

tissues.

One

is

3-hydroxykynurenine

glucoside which is found in the lens (van Heyningen, 1971 a) and
the other is bilirubin glucoside (Fevery et al. 1971) which has
been identified in bile. The existence of these glucosides provides
evidence

that

mammals

can

form

glucosides

as

well

as

glucuronides.
It is believed that the tryptophan metabolism and glucoside
formation both take place in the layer of epithelial cells on the

6

anterior surface of the lens. In their recent research, Wood and
Truscott

(1993)

proposed

hydroxykynurenine
cells,

and

a model

which

suggested

that

3-

glucoside was synthesised in the epithelial

possibly

the

cortical

region,

and

then

diffused

throughout the remainder of the lens. It is believed that the
formation of the glucoside is via a uridine diphosphate glucose
(UDPglucose) pathway as illustrated below.

+
Phenol

UDP

Phenyl-ß-glucoside

1.4

The

m ajor

the

prim ate

role

of

3-hydroxykynurenine

glucoside

lens

Surprisingly little research has been performed on the role
of 3-hydroxykynurenine glucoside in the lens, despite its potential
importance

in

the

lens.

The

first

measurements

of the UV

absorption of the yellow substances obtained from human lens
were performed by Walls (1942) and Cooper et al. (1969) who
p u rifie d

th ese

w a te r-so lu b le

yellow

su b stan ce s

by

in

7

chromatography, finding a fast-moving component with a blue
fluorescence and maximum UV absorption at 365nm. However, it
was not until van Heyningen (1971a) first identified this yellow
compound as 3-hydroxykynurenine glucoside, that the some of
the functions of this compound has been gradually revealed.
Based on the principle that 3-hydroxykynurenine glucoside
can absorb light in the 300-400nm band (with a maximum at
365nm), it is possible that the major role of 3-hydroxykynurenine
glucoside in human lenses is to eliminate the near-ultraviolet
band as light passes through cornea. The cornea filters out all light
below 300nm. This function of absorbing the near-ultraviolet light
may protect the human lens.
Secondly, Dillon and Atherton (1990) found that the excited
state of 3-hydroxykynurenine glucoside decays rapidly and acted
as a relatively inefficient sensitising agent for lens proteins.
Hence, another role of 3-hydroxykynurenine glucoside could be to
minimise photochemical insult to the lens.
Finally, recent work has demonstrated that 3-hydroxy
kynurenine glucoside effluxes continuously from human lenses
(Wood and Truscott, 1993) and it is possible that it may play an
unknown signalling role in the eye.
Further work on the role of 3-hydroxykynurenine glucoside
has in part been restricted by the lack of synthetic material
available. Until now, all of the 3-hydroxykynurenine glucoside
used in this area of research has been isolated from lenses by
extraction followed by electrophoresis (van Heyningen, 1971b) or
purification by way of a Sephadex G-15 column (Bando et al.

8

1980). The approximate concentration

of 3-hydroxykynurenine

glucoside in the lens is only 1.54 pm ol/g lens (van Heyningen,
1973a), which making this isolation a formidable task.
Thus a major aim of this work is to chemically synthesise 3hydroxykynurenine glucoside to enable more effective research
about the function of 3-hydroxykynurenine glucoside in human
lens to be conducted.

1.5.

Lens

crystallin s

Many physical and pathological changes take place in the
lens with age. Some changes are obvious, such as increasing
weight, thickness and yellowness, and decreasing accommodative
power (presbyopia). Other changes, such as peripheral opacities,
increasing fluorescence, decreasing activities of a variety of
enzymes and increasing post-translational modification of the lens
proteins (the crystallins), are not so obvious. Some of these
changes,

which

involve

lens

proteins

(Harding,

1991),

are

observable to a greater extent in cataract and are thought to be
responsible for the increased opacity of the lens with cataract.
The lens contains a high concentration of structural proteins
which comprise approximately 35% of the whole lens by weight.
Lens proteins may be subdivided into two groups, the watersoluble crystallins and a water-insoluble fraction (van Heyningen,
1973a).

The particular

structural

arrangement

of these

lens

proteins is responsible for the transmission and focussing of light
onto the retina.

9

With size exclusion gel chromatography (Kleimam et al.,
1988),

the

water-soluble

mammalian

lens

proteins

can

be

separated in order as aggregated protein (HM), a-crystallins, pH-,
pLi, pL2-crystallins, and Ys-, Y-crystallins. The aggregated protein,
which

is

also

called

high-molecular-weight

protein,

has

a

molecular weight greater than a million. Chiou and Azari (1989);
Liang and Rossi (1989) found in bovine lens this aggregated
protein appeares to be a partly unfolded form of a-crystallins. acrystallins and p-crystallins are present as high aggregates (acrystallins), octomers (pH-crystallin), trimers (pLl-crystallin) and
dimers (pL2-crystallin) which form the major part of the lens
protein,

a-C rystallins

are composed

of two

closely

related

subunits aA and aB. Both of these subunits have a molecular
weight of approximately 20 kDa. The p-crystallins are composed
of three basic subunits and four acidic subunits whose molecular
masses range from 23 to 33 kDa. y-Crystallins are monomers with
molecular masses of about 20 kDa. (Harding, et al., 1976; Harding,
1992).
Although the size of these crystallin aggregates is influenced
by many factors such as temperature (Tompson and Augusteyn,
1983), ionic strength and pH (Van den Octelaar, et al., 1988),
recent research has found that the crystallin terminal extensions
play major roles in forming the aggregates. In their recent *H
NMR studies, Carver et al. (1992, 1993) and Cooper et al. (1993)
have confirmed that p-crystallin subunits have both C-terminal
and N-terminal extensions while the four acidic p -c ry sta llin
subunits have N-terminal extensions only. They also confirmed
that monomeric Y_crysIa^in does not have any significant C- or N-
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terminal extensions which suggests that the C- and N-terminal
extensions may play major roles in forming a - and p-crystallin
aggregates (Carver and Truscott, unpublished results).
Until now, the function of these terminal extensions has not
been very clear, however, it has been speculated that they act as
attachment sites for oligomer formation or for binding to other
cellular components.
These crystallin aggregates are one level of the lens protein
arrangement, and this arrangement is capable of maintaining lens
transparency.

In

this

sense,

the

terminal

extensions

of the

crystallins have great importance. It has been confirmed that the
terminal extensions have great conformational flexibility and
move independently of each other in the aggregates (Carver, et al.,
1992, 1993). This property makes the terminal extensions easier
to be digested and cleaved by proteases (which exist in the eye)
than the bulk of crystallins. In their proteolytic studies, Yoshida et
al. (1986) have found that a variety of proteases can cleave the Cterminal of aA crystallin. Some age-related degradation of the Cterminal extensions of aA and pH crystallins have also been found
by

recent

electrospray

mass

spectrometry

analysis

(Kilby,

Truscott and Sheil, unpublished result).
a-Crystallin is normally present as an 800 kDa multimer
containing

aA and aB

subunits. In their NMR spectroscopy

research, Carver et al. (1992) have confirmed that the last eight
amino acids in the aA

C-terminal

extension

(K-P-S-S-A-P-S-S

166-173) and the last ten amino acids in the aB
extension

(K -P-A -V -T-A -A -P-K -K

166-175)

C-terminal
have

great

11

conformational flexibility and move independently of each other
in the bovine lens a-crystallin aggregates.
Because the crystallins play an important role in the lens,
revelation of their metabolism can lead to more understanding
about the lens and its diseases. The metabolism of the lens
crystallins may be divided into two aspects, their synthesis and
breakdown. Synthesis of lens crystallins is continuous throughout
life and new cells which are formed in the epithelial layer,
elongate and add to the old cells peripherally. The amino acids
required for the synthesis of crystallins are transported into the
lens from the aqueous humour. As a result of this new cell
formation, the lens grows bigger, thicker and heaver with ageing
(Harding
breakdown

and
has

Crabbe,

1984).

concentrated

The
on

study

the

of lens

effects

of

crystallin
proteolytic

enzymes. In the normal breakdown pathway the lens crystallins
are first digested by endopeptidases, the resulting peptides are
then eliminated by stepwise degradation by peptidases. Both
endopeptidases and peptidases have been separated from and
identified in human and bovine lenses (van Heyningen and Wale,
1963; Harding and Crabbe, 1984; Taylor et al., 1984). However,
overall the rate of crystallin breakdown is very small.
This work was aimed at using gel filtration techniques to
purify pB2 and aA crystallins from foetal and ageing bovine lens.
Then a tryptic digestion method was used to cleave the C-terminal
extensions of PB2 and aA

crystallins.

Simultaneously,

the

synthetic model polypeptides of C-terminal extensions of pB2 and
aA crystallins were treated at the same way. HPLC was used to
separate and purify the C-terminal residues of pB2 and a A

12
crystallins according to the retention time obtained from model Cterm inal polypeptides. Capillary electrophoresis and electrospray
mass spectrometry are used to identify that there was a serine
lost from the C-terminal of the both crystallins with ageing. The
purpose of this work was to confirm that C-terminal serine was
lost,

which

suggests

that

there

are

carboxypeptidase

A-like

enzymes in the bovine lens which digest the C-terminal residue of
the pB2 and ocA crystallins during the ageing process.

1.6.

C ap illary

E lectrophoresis

Fig. 4. Schematic diagram of a capillary electrophoresis system.
Figure

4.

electrophoresis

shows

a

instrum ent

schematic

diagram of a

which consists

of a

capillary

fused

silica

capillary column, two electrolyte buffer reservoirs, a detector (UV
absorbance is the most common) with data integrator and a highvoltage (30 kV) power supply. The fused silica capillary columns
range from 10 to 100 cm in length, with inner diameters of 20 to
200 pm and the detector is placed near the end of the

capillary
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column. The inside wall of the fused silica capillary column is
negatively charged over a wide pH range in aqueous solution,
because its surface is covered by silanol groups. When a voltage is
applied, there is a nett flow of the buffer, referred to as the
electroosmotic flow, caused by the electrical double layer formed
at the wall-electrolyte interface. When the flow is towards the
cathode (inlet positive) any components with a positive charge
emerge early because both the electrophoretic motion of the ion
and the electroosmotic flow of the buffer are in the same
direction. Negatively charged components also migrate toward the
cathode, provided their electrophoretic mobility is less than the
electroosmotic

flow,

but

with

a

much

lower

rate.

The

electroosmotic flow and mobilities are governed by the nature and
concentration of the buffer, the applied voltage and the length of
capillary. Hence these parameters can be varied to control the
component to be separation.
Thus, this work relates to determining the optimum CE
operating conditions for short peptides (< 3000 Da) separation.
Capillary

electrophoresis

(CE)

was

first

described

by

Virtanen (1974), but it did not show a significant growth in
popularity as an analytical technique until Jorgenson and Lukács
did the pivotal work in early 1980s with narrow bore capillaries
(1981). Commercial CE systems became available in 1990 and due
to its simplicity, high resolution, ease of quantification and ability
to perform rapid automated analysis of multiple samples, CE has
been widely applied in the field of biochemistry and molecular
biology, [see for example recent reviews by Gordon et al. (1988);
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Ewing et al. (1989), Drossman, H. et al. (1990), Kuhr, W. G. and
Moning, C. A. (1992) and Xu,Y. (1993)].

1.7.

E lectrosp ray

Electrospray
developed

M ass

Mass

technique

Spectrom etry

Spectrometry

which

has

(EMS)

enabled

is

accurate

a recentlymolecular

weight determination of proteins and other biomolecules up to
150kDa. EMS is becoming a vital tool in the biological and
biochemical research areas [see for example the recent reviews by
Today’s Life Science (1992) and Smith et al. (1990)].
With electrospray mass spectrometry the sample solution is
introduced

into the atmospheric pressure ion

source of the

spectrometer through a silica or stainless steel capillary tube. As a
consequence of the strong electric field between the end of the
capillary and the counter electrode, the sample solution emerging
from the capillary is dispersed into an aerosol of highly charged
droplets - the electrospray. These droplets, assisted by a flow of
warm gas flowing through the source, diminish in size by
evaporation until a point is reached where multi-charged ions of
individual protein molecules, free of solvent, are released. Some of
these ions pass through a small hole (the sampling orifice) into a
pumped intermediate vacuum region at about 1 mbar pressure
and then through a second small hole (the skimmer) into the
quadrupole
m easured.

analyser,

where

their

mass-to-charge

ratios

are

15

With proteins, a multiply-charged

envelope is normally

produced, thus enabling determination of molecular weights with
accuracies of the order of 0.1%.

1.8. Aims of this work

Thus
problems

this
for

thesis
lens

hydroxykynurenine

attempts

research.
glucoside

to

address

two

the

synthesis

Firstly,
was

tried

by

three

important
of

3-

different

methods, with the goal of finding a cost effective method of
obtaining this compound for the further study of its role in the
lens. Secondly, the proteins aA crystallin and pB2 crystallin from
bovine lenses were studied in aged and foetal lenses in an attempt
to confirm an age-related loss of serine from the C-terminal
extension of these proteins, which in turn may be an indicator of
enzymatic activity in the lens.
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CHAPTER 2
CHEMICAL SYNTHESIS OF 3-HYDROXYKYNURENINE
GLUCOSIDE: METHOD ONE

Three methods were tried for the synthesis of 3-hydroxykynurenine glucoside.
The starting materials for synthesis method one were 3hydroxykynurenine and methyl a-D-pyranoside. As there were
several

reactive

groups

on

both

starting

materials,

it

was

necessary to block the sites at which the reactions were not
desired in order to reduce the formation of side products.
The

strategy

for

synthesis

of

3-hydroxykynurenine

glucoside according to this method is shown in Scheme 2.

2.1.

B locking

reactive

sites

in

3-hydroxykynurenine

Since 3-hydroxykynurenine is a phenol, the aim of this
synthesis was for the glucose to be attached to the hydroxy group.
However, 3-hydroxykynurenine also has an amino acid group
which is potentially very reactive. Thus, in order to get a high
yield, methylation was chosen to block the -COOH group of 3hydroxykynurenine.

This

was

performed

by

adding

3-

hydroxykynurenine to 10% thionyl chloride in methanol or 10%
hydrochloric acid moisture (by weight) acidified methanol. After
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the reaction was complete, a new UV reactive spot appeared on
the TLC, with a slightly greater Rf value than the starting
material, which was identified as 3-hydroxykynurenine methyl
ester.
The amino group of 3-hydroxykynurenine was blocked
using 2 equivalents of methyl trifluoroacetate and 2 equivalents
of triethylamine in methanol to generate the N-trifluoroacetic acid
(TFA) methyl ester. The mixture was then stirred at room
temperature until the 3-hydroxykynurenine methyl ester spot
disappeared on TLC. Purification was performed by column
chromatography

on

silica.

The

N-TFA-3-hydroxykynurenine

methyl ester was obtained in 60% yield. The negative and the
positive ESI mass spectra gave the molecular weight data at 333
and 335, for [M-H]~ and [M+H]+ ions respectively, consistent with
the N-TFA-3-hydroxykynurenine methyl ester molecular weight
of 334. The

NMR spectrum showed three aromatic resonances

at 57.51, 7.20 and 5 6.77 as three doublets. A singlet at 53.71 also
indicated that there were three methyl protons. All of these
analytical data indicate that these two steps of the synthesis were
successful.
There is another amino group on the aromatic ring at
position 2. The reactivity of this group is reduced due to the effect
of steric hindrance, hence, blocking is not required.

2.2.

Blocking

hydroxyl

groups

on methyl

a-D-pyranoside

Methyl a-D-glucopyranoside was used as a starting material.
In this two step reaction, based on the method of Glaudemans et
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al.

(1972), the hydroxy groups were first blocked by benzyl

groups and secondly the methyl group on C-l was converted to a
hydroxy group.
The reaction was performed by dissolving methyl a - D glucopyranoside

and

powdered

potassium

hydroxide

in

dry

dioxan. Benzyl chloride was added to block the four hydroxy
groups of the methyl a-D-glucopyranoside. At the end of this
reaction,

the

crude

product,

methyl

tetrabenzylglucose,

was

of methyl

tetrabenzylglucose

was

obtained as a syrup in 95% yield.
The

methoxy

group

converted to a hydroxy group by dissolving the syrup in boiling
glacial acetic acid and diluting with boiling 2M sulphuric acid
twice. The 2M sulphuric acid must be kept boiling when pouring it
into the boiling mixture, otherwise a syrup will form which is
difficult to redissolve. After cooling, the mixture was poured into
water. The crystals which formed in the water were recrystallized
from methanol to obtain tetrabenzylglucose as white crystals with
70% yield. The NMR spectrum and the melting point at 142°C
(literature 143°C) were consistent with the structure.

2.3.
ester

Coupling
to

of

N-TFA-3-hydroxykynurenine

methyl

2,3,4,6-tetra-o - b e n z y 1 - g l u c o p y r a n o s e ( t e t r a 

benzylglucose)
The

coupling

reaction

employed

a fusion

method

of

Tsutsumi and Ishido (1981) in which tetrabenzylglucose is first
fused with dicyclohexylcarbodiimide (DCC) and copper (I) chloride
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is involved as a catalyst. In this stage the tetrabenzylglucose was
converted to O -(tetrabenzylglucose) pseudourea. Thus, based on
the principle that pseudourea formation will make the compound
more nucleofugal, the only free hydroxyl group on the anomeric
carbon atom (the others were blocked by benzyl groups) becomes
very reactive. After phenol was added in the second stage, the
coupling should then involve in a simple SN2 reaction. In the
model experiments using this reaction with forty-nine phenols
(Tsutsumi and Ishido, 1981), the highest yield was 93%.
For this work, it was necessary to slightly alter this fusion
method as the 3-hydroxykynurenine is a phenol which is not
stable at high temperature. In the presence of Cu(I), chloroform
was used as solvent, so the coupling reaction could be carried out
at room temperature. At the end of the first step, after the O(tetrabenzylglucose)

pseudourea

was

formed,

the

catalyst

(copper(I) cloride) was washed out using 0.5 M aqueous ammonia
solution, followed by water.
As

the

temperature,

coupling
the

reaction

mixture

was

was
kept

carried
stirring

out

at

a low

for 4 days

to

maximise the yield (see general procedure 4.1.3 for the details).
The final product was a yellow-white solid obtained with 70%
yield.

2.4.

Débenzylation

The deprotection

(deprotection

of

tetrabenzylglucose)

of N-TFA-3-hydroxykynurenine

methyl

ester was performed in dry glacial acetic acid with 10% palladium
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on

activated

carbon

as

a

catalyst

and

under

a hydrogen

the

débenzylation

atm osphere.
The

NMR

data

showed

that

was

unsuccessful. There are two possible reasons which may have
caused the failure of the reaction. First, the TFA group on the
starting

m eterial,

N-TFA-3-hydroxykynurenine,

poisoned

the catalyst.

Alternatively,

may

after débenzylation

have
was

complete, the glucoside may have hydrolysed, being split into NTFA-3-hydroxykynurenine methyl ester and glucose immediately
by the acetic acid if the acetic acid was not absolutely dry.
The failure of the débenzylation step prevented any further
progress with this method.

o

SCHEME 3

Strategy 2 towards the synthesis of
the 3-hydroxykynurenine glucoside
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CHAPTER 3
CHEMICAL SYNTHESIS OF 3-HYDROXYKYNURENINE
GLUCOSIDE: METHOD TWO

The rationale behind this method of synthesis was to use
basic, readily available starting materials to enable large amounts
of 3-hydroxykynurenine glucoside to be prepared. The starting
materials involved in this synthesis were 3-hydroxyacetophenone
and D-(+)-glucose.
The synthetic strategy is shown in scheme 3.

3.1

Preparation

of

2-nitro-3-hydroxyacetophenone

from

3-h yd roxyacetop h en on e

This reaction employed a nitration method which was
carried

out

by

treating

3-hydroxyacetophenone

with

acetic

anhydride and cupric nitrate trihydrate in dry glacial acetic acid
at low temperature (Butenandt et al., 1957). The nitro group
added to the C2, C4 and C6 positions of the aromatic ring, so this
reaction gives a mixture which contains three nitro-isomers.
Fractional recrystallisation from benzene was used to separate the
three nitro-isomers, which was a key step of this reaction in
determining the overall yield, (see general procedure 4.2.1 for the
details). The required isomer was a yellow solid which was
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obtained in 8.1% yield. This isomer was identified by the NMR
spectrum showing three doublets of doublets resonating at 57.68
7.50, 57.26-7.14, 56.87-6.77 for the three aromatic protons, and a
singlet resonating at 52.51 for the three methyl protons. The other
two nitro-isomers had NMR chemical shifts clearly different from
the desired compound. The MS spectrum with 182 (M+) and the
melting point at 135°C (literature 138°C) confirmed the synthesis
of the required compound.

3.2.

P reparation

pyranosyl

b ro m id e

Acetobromoglucose

of

2 ,3 ,4 ,6 -te tr a a c e ty l-a - g 1u c o ■

(a c e to b r o m o g lu c o s e )

was

prepared

by

the

method

from

Vogel’s Textbook of Practical Organic Chemistry (Furniss, et al.,
1989). This method used D-(+)-glucose as the starting material. In
the reaction, with acetic anhydride as solvent, red phosphorus and
bromine as reagents, and perchloric acid as a catalyst, the 2,3,4,6hydroxy groups were blocked by acetyl groups and the 1-hydroxy
group was substituted by a bromine. The crude product obtained
was recrystallised from ether-hexane giving acetobromoglucose as
white crystals. The melting point of 87°C (literature 88-89°C), and
the Iff NMR spectrum which shows the Cl proton as a doublet at
56.63 and 56.58, and the four acetyl group protons as three
singlets at 52.09, 2.04 and 2.01, confirmed this compound was the
desired product.
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3.3.

C ou p lin g

2-n itro-3-h yd roxyacetop h en on e

w ith

acetob rom oglu cose

In this method glucose was attached to the 2-nitro-3hydroxyacetophenone

via

a

coupling

reaction

with

aceto

bromoglucose.
Theoretically, this coupling step could be easily affected in
basic

conditions,

so

after

dissolving

2-nitro-3-hydroxyaceto-

phenone in dry acetone, potassium carbonate was added. The
acetobromoglucose was added to the mixture dropwise because it
was not very stable in base. After reaction, the crude product was
recrystallized

from

ether

to

give

the

pure

2-nitro-3-

hydroxyacetophenone acetoglucoside as a white solid obtained in
80% yield. The NMR spectrum showed four acetate proton groups
at 82.01, 2.02, 2.07, 2.11 and three methyl protons as a singlet at
82.56. At 83.89 and 5.21 there were five sugar protons and there
were three aromatic protons with chemical shifts of 87.53. The
NMR data and the melting point of 168°C confirmed the identity
of this product.

3.4.

B rom ination

of

2-nitro-3-hydroxyacetophenone

tetra a ceto g lu co sid e

This reaction used dioxan dibromide as the brominating
reagent which was prepared by a simple synthesis modified from
the method of Pasaribuet and William, (1973).
The dioxane dibromide was prepared by dissolving dioxane
in hexane and adding 1 equivalent of bromine over 10 min. The
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orange crystals which precipitated from solution were dioxan
dibromide. This brominating reagent should be used immediately
or stored at the temperature below -20°C as it is both hydroscopic
and volatile.
The brominating reaction was performed by adding dioxane
dibrom ide

to

2-nitro-3-hydroxy-acetophenone

tetraaceto-

glucoside dichloromethane solution. Recrystallization from ethanol
gave

the

a-bromo-2-nitro-3-hydroxyacetophenone

tetraacetoglucoside as a white solid with a 66% yield. In this
reaction the key aspects are the amount of dioxane dibromide
added and the reaction time. If too much dioxane dibromide and
/or too long a reaction time is used, dibromination would take
place on the a carbon. The lH NMR data showed three aromatic
protons at 87.56 as a singlet and the four acetyl group protons
were at 82.03, 2.04, 2.09 and 2.13. After bromination the chemical
shift of the protons on the a carbon changed from 82.56 to 4.30.
The 1 3 c

NMR

spectrum

confirmed

that this

synthesis

was

successful.

3.5

Coupling

o c-b ro m o -2 -n itro -3 -h y d ro x y a ceto p h en o n e

te tr a a c e to g lu c o s id e

This

reaction

with

used

ethyl

ethyl

n itroacetate

nitroacetate

as

a reagent

to

introduce the nitroacetate group to the a - b r o mo - 2 - n i t r o - 3 hydroxyacetophenone tetraacetoglucoside and NaH was used to
form the carbanion. After reaction the DMF was removed under
vacuum and the residue was purified on a preparative TLC plate.
Three main spots were collected for NMR analysis.

The NMR spectrum of the second spot showed that the
coupling reaction worked but in a very low yield. Thus more work
is required to optimize the reaction conditions for this step but
this could not be accomplished within the time frame of this
project, hence no further work was done on the remaining steps
for this method.

o

ch 2oh

nh2

I

SCHEME 4.

Strategy 3 towards the synthesis of
the 3-hydroxykynurenine glycoside
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CHAPTER 4
CHEMICAL SYNTHESIS OF 3-HYDROXYKYNURENINE
GLUCOSIDE: METHOD THREE

This final method combined the most promising aspects of
the previous two unsuccessful syntheses.
In this synthesis, 3-hydroxykynurenine and a-D -(+)-glucose
were chosen as the starting materials, but the glucose was blocked
in the same manner as was the acetobromoglucose in the method
two.

This

is

less

desirable

than

strategy

2

since

3-

hydroxykynurenine is a much more expensive starting material
than

3-hydroxyacetophenone.
The proposed synthetic strategy for synthesis 3 is shown in

Scheme 4.

4.1.

Synthesis

of

3-hydroxykynurenine

glucoside

In this two step synthetic method, 3-hydroxykynurenine
was dissolved in a sodium carbonate/sodium hydrogen carbonate
buffer (pH 10.5). The phenol group of 3-hydroxykynurenine was
converted to a phenoxide ion under these basic conditions in
order to make it reactive. This change ensured the following
coupling reaction proceeded more easily. The amino acid groups of
3-hydroxykynurenine also became more reactive, this contributes
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to the formation of undesirable side products. After the phenoxide
ion formed, acetobromoglucose in acetone was added dropwise
over

four

hours.

This

extended

period

of

adding

acetobromoglucose was required because the acetobromoglucose
was unstable under the basic conditions. Another function of the
sodium

carbonate/sodium

hydrogen

carbonate

buffer

was

to

neutralize the HBr which was formed in the coupling reaction and
to maintain the pH of the reaction mixture at 10.5.
After the reaction had finished, three new UV-reactive spots
appeared on the TLC plate. One of these newly formed spots had a
bright-blue fluorescence, possibly due to the 3-hydroxy group
being blocked (van Heyningen,
analysis

showed

corresponds

to

1973a). The electrospray MS

the

molecular

weight

to

the

molecular

weight

of

be

554

which

acetylated

3-

hydroxykynurenine glucoside.
Thus, given that TLC and electrospray MS analyses showed
that the coupling reaction had worked, sodium hydroxide was
used

to de-acetylate

the coupled product to obtain

the 3-

hydroxykynurenine glucoside.

4.2.

Purification

of

3-hydroxykynurenine

glucoside

After de-acetylation, the solvent was removed from the
reaction

mixture

under

vacuum.

The

first

separation

was

performed using a C l8 cartridge. The aim of this step was to
separate the water soluble 3-hydroxykynurenine glucoside from
undesired compounds which were water insoluble and also to
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d esalt the sam ple. The fractio n s w hich eluted by w ater from

the

C l 8 cartrid g e w ere collected and dried. They w ere redissolved in
th e

H PL C

b u ffe r

and

in je c te d

to

the

H PL C

fo r

the

second

separation (see general procedure 7.3 for details).
The resulting H PLC chrom atogram is shown in Fig.5

Fig. 5. HPLC profile of the purification of 3-hydroxykynurenine
glucoside. The numbers above the peaks are retention time in minutes. The compounds
were shown to be 3-hydroxykynurenine (14.48 min), 3-hydroxykynurenine aglucoside (16.86 min) and 3-hydroxykynurenine p-glucoside (17.5 min). This HPLC
separation method was adopted from Wood and Truscott (1993).
T he

3 -h y d ro x y k y n u re n in e

g lu c o sid e

p eak

was

co lle c te d

fo llo w in g H PLC separation and dried under vacuum . In order to
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test

the

product,

a

small

portion

of

synthetic

'3-

hydroxykynurenine glucoside' was taken and hydrolysed with 0glucosidase.

The

hydrolysed

3-hydroxykynurenine

glucoside

solution was then reinjected onto HPLC. The HPLC chromatogram
showed that a 3-hydroxykynurenine peak had appeared while
the

’glucoside'

peak

disappeared.

The

hydrolysed

3-

hydroxykynurenine glucoside also separated by TLC with Butanol:
Acetic acid : Water (4:2:1) as the developing solvent, and staining
with

silver

nitrate-sodium

hydroxide.

The

stained

glucose

appeared with dark brown colour and an Rf value of 0.38. The
third

test

was

hydroxykynurenine

performed
glucoside

by

mixing

with

the

the

synthetic

3-

3-hydroxykynurenine

glucoside extracted from human lens (Wood and Truscott, 1993),
and reinjecting the mixture onto HPLC. The HPLC chromatogram
showed that the 3-hydroxykynurenine P-glucoside peak had not
broadened and the retention time had not changed.
Further purification and desalting was performed by the
way of chromatography employing a Sephadex G10 column. The
sample was eluted with water at a flow rate of 5ml/hr and 1.5ml
each fractions were collected. The UV absorbances of the fractions
were measured at 229nm and 365nm.
The obtained LC profiles are shown in Fig. 6.
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Fig. 6. The Sephadex column chromatography profile of purification and
desalting synthetic 3-hydroxykynurenine glucoside sample.

The fractions from 20 to 29 were combined and dried under
vacuum to give the pure 3-hydroxykynurenine glucoside.
The lH NMR spectrum (D2 O) showed three aromatic protons
at the chemical shifts of 57.48, 7.16, and 6.61. The a carbon proton
occurs at 53.63, and (3 carbon protons at the chemical shifts of
53.61, 3.36 as a doublets of doublets. The C l sugar proton is a
doublet at 5 4.9, and the other sugar protons are a multiplet at
53.46. The C'6 sugar protons are a doublet at 53.78.
The UV spectrum showed the synthesised compound had
three absorption maxima at 365, 263 and 227nm which match the
published

data

for

3-hydroxykynurenine

glucoside.

The

UV

absorption of 3-hydroxykynurenine is at 368, 267 and 368nm
(Bando, et al 1981).
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Fig. 7. UV-Spectra of 3-hydroxykynurenine glucoside (1) and 3hydroxykynurenine (2).
T he
m o le cu lar

e le c tro s p ra y
ion

at

386

MS

sp e ctru m

co n sisten t

glucoside m olecular w eight of 385.

with

sh o w ed
the

a

p ro to n a te d

3 -h y d ro x y k y n u ren ine
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s y n th e s is e d
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Fig.8. The three dimensional fluorescence spectrum of 3-hydroxykynurenine
glucoside.
T hus,
m eth o d

fo r

su c c e ssfu l.

the

analytical

sy n th e sis

of

data

above

proves

3 -h y d ro x y k y n u ren in e

that

this

g lu co sid e

third
was
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Amino acid

sequence

of a A-crystallin

6

11

from

bovine

16

21

1

MDIAI

QHP WF KRTLG

P F YP S

RLFDQ

26

FFGEG

LFEYD

LLPFL

S S TI S

PYYRQ

51

SLFLT

VLDSG

R S E VR

SDRDK

FVIFL

76

D VKHF

SPEDL

T VK VQ E D F V E

IHGKH

101 N E R Q D

DHGYI

SREFH

RR Y R L

PSNVD

126 QS A L S

CSLS A

DGMLT FSGPK

IPSG V

151

ARAIP

VSREE

D AGHS

KP S S A

lens

PSS

Number of residues=173

Amino

acid

sequences

of

synthetic

poly-peptide

SREEKPSSAPSS

SCHEME. 5. Amino acid sequences of bovine lens a A crystallin. In this experiment, trypsin was used to cleave the Cterminal extensions from both a A-crystallin and the synthetic
polypeptide. Carboxypeptidase A was used to cleave serine from
the

synthetic

polypeptide

to generate

the corresponding

terminal extension of aA-crystallin minus serine.

C-
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sequence

Amino acid

of bovine

lens

PB2 - c r y s t a l l

6

11

16

21

1

ASDHQ

TQAGK

PQPLN

P K 111

FEQEN

26

FQGHS

HELNG

PCPNL

KETGV

EKAGS

51

V L V Q A GP W V G Y E Q A N

CKGEQ

F VFEK

76

GE Y P R

W D S WT S S R R T

DSLSS

LRPIK

101

VDSQE

HKITL

YENPN

FTGKK

ME V I D

126

DD VPS

F H A H G YQEKV

SS V R V

QSGTW

151

VGYQY

PGYRG

LQ Y L L

EKGDY

KDSGD

176

F GAPQ

PQ V Q S

VRRI R

DMQWH

Q RG AF

201

HP S S

Number of residues=204

Amino

acid

sequences

of

synthetic

poly-peptide

MQWHQRGAFHPS S

SCHEME. 6. Amino acid sequences of bovine lens pB2
crystallin. In this experiment, trypsin was used to cleave the Cterminal extensions from both pB2-crystallin and the synthetic
polypeptide. Carboxypeptidase A was used to cleave serine from
the

synthetic

polypeptide

to generate

the corresponding

terminal extension of PB 2-crystallin minus serine.

C-
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ASDHQTQAGKPQPL
NPKIIIFEQENFQGH
SHELNGPCPNLKET
GVEKAGSVLVQAGP
WVGYEQANCKGEQ
FVFEKGEYPRWDSW
TSSRRTDSLSSLRPIK
VDSQEHKITLYENP
NFTGKKMEVIDDD
VPSFHAHGYQEKVS
VRVQSGTWVGYQY
PGYRGLQYLLEKGD
YKDSGDFGAPQPQV
QS VRRI RDMQWHQR
G AFHPSS

Carboxypeptidase A
like proteinase digest
the pB2-crystallin of the
bovine lens through out
the life. A serine is
cleaved from the
C-terminal extension

ASDHQTQAGKPQPL
NPKIIIFEQENFQGH
SHELNGPCPNLKET
GVEKAGSVLVQAGP
WVGYEQANCKGEQ
FVFEKGEYPRWDSW
TSSRRTDSLSSLRPIK
VDSQEHKITLYENP
NFTGKKMEVIDDD
VPSFHAHGYQEKVS
VRVQSGTWVGYQY
PGYRGLQYLLEKGD
YKDSGDFGAPQPQV
QS VRRI RDMQWHQR
G A F HP S

P B 21-204

PB 2 1-203

Tryptic digestion
G AFHPSS,

G AFHPS

and PB2i „ i 97

H
Confirmation of the C-terminal serine
loss of the bovine lens pB2crystallin

SCHEME. 7. General diagram of the method of confirmation
of the C-terminal serine loss of pB2-crystallin
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CHAPTER 5
SEPARATION AND ANALYSIS OF BOVINE LENS
CRYSTALLINS

As mentioned in chapter one, the lens crystallins

are

digested to some extent by a range of enzymes throughout the
life of

the lens. The N-

and C-terminal extensions of the

crystallins are relatively independent from the globular domains,
so the residues on the terminal extensions may be more readily
digested by enzymes. In this work, based on the discovery of
proteins accompanied

by

apparent

serine

loss

species by

electrospray mass spectrometry, we attempted to use the method
shown in scheme 7 to confirm this serine loss is from the Cterminal extensions of the aA and (3B2 crystallins from bovine
lens.
Firstly, digestion with the enzyme trypsin (which specially
cleaves proteins or peptides at arginine and lysine residues) was
used to cleave the C-terminal extensions of the a A and (3B 2
crystallins. The resulting C-terminal peptides were separated and
purified by High Performance Liquid Chromatography (HPLC). At
the

same

time,

a

synthetic

C-terminal

extension

model

polypeptide for the normal sequence and a serine loss C-terminal
extension

model

polypeptide

(serine

was

cleaved

by

carboxypeptidase A from the normal C-terminal extension model
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polypeptide) were treated in the same way, to get the required
HPLC retention times of the trypsin-cleaved C-terminal peptides.
Then it was aimed to use the high resolution capability of the
capillary electrophoresis (CE), and the accurate molecular weights
determined by

electrospray mass spectrometry as the methods to

analysis of the HPLC fraction to confirm that there is a serine loss
from the C-terminal extension of aA and (3B2 lens crystallins.

5.1.

Separation

of

bovine

lens

crystallins

This crystallin separation method is modified from that
published by Kleiman et al. (1988).
Nine-year-old bovine eyes were obtained from a local
abattoir and the foetal bovine lens protein was obtained from Dr.
R. C. Augusteyn, National Institute of Vision Research, Melbourne.
The age of the animal was calculated from the weight of the lens
using the following formula:
W=IA02 log(f + 9.3) -0.221
where w is grams and t is number of months (Hockwin, 1987).
The lenses were removed from the eyes and the crystallins
were extracted in a 50mM Tris/HCl (pH=7.5), ImM EDTA, O.lmM
phenylmethylsulfonyl

fluoride,

0.02%

buffer (2ml/gram

sodium

azide

O.lmM

1,4-dithiothreitol
lens)

using

and

a glass

homogenizer. The insoluble material was removed by centrifuging
at 15000 G for 20 minutes at room temperature. The supernatant
containing

the

water-soluble

crystallins

was

loaded

on

a
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Sepharose CL-6B column which had been equilibrated in 50mM
Tris/HCl (pH=6.8) buffer. The same buffer was used to separate
the crystallins with the flow rate of 16ml/hr and 3.75ml fractions
were collected. Fractions 39 to 48 were collected as a-crystallins,
fractions 50 to 56 were collected as (3 high (pH) crystallin, 57 to 60
were collected as p low 1 (pLl) crystallin and 61 to 67 were
collected as p low 2 (PL2) crystallin. These p fractions represent
different molecular fractions of the aggregated p subunits. The gel
filtration chromatography profile is shown in figure 9. The
remaining crystallin class, i.e. y crystallins, were not of interest for
this work.

Fig. 9. The profile of the 9-year-old bovine lens crystallins
separation
The

separated

concentrated

pH and PL2

crystallin

fractions

were

on a stirred ultrafiltration cell and completely

dialysed against Milli Q water before lyophilisation in a freeze
drier. The dried crystallin samples were stored at 4°C, prior to
electrospray mass spectrometry analysis and tryptic digestion.
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a-C rystallin

fractions

were

concentrated

on

a

stirred

ultrafiltration cell and reloaded on a Sephadex G-75 column
which was equilibrated

with 0.1M glycine at pH 2.5. The

individual a A and ocB subunits were eluted by the same buffer
with the flow rate at 13ml/hour and 6.5 ml fractions were
collected. Fractions 20 to 31 were pooled as a A and fractions 36 to
45 were gathered as aB crystallins. The aA and ocB collections
were concentrated, dialysed and freeze dried in the same way as
p -crystallins and were stored at 4°C.

F r a c t i o ns

Fig. 10. The elution profile for separation of total acrystallin into subunits.
The purity of the samples was checked by electrospray mass
spectrometry using the method described in general procedures
(chapter 7). The mass spectra of p High and a fractions are shown
in Fig. 11 and 12 respectively. In these spectra a-crystallins give
molecular weights of aA 19834 Da; phosphorylated aA 19914 Da;
aB 20082 Da, and phosphorylated aB at 20163 Da. In all of the pH,
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PL1 and pL2-crystallins fractions studied there is a large PB2 peak
at molecular weight 23210 Da, which is consistent with earlier
work showing this to be the major component in each fraction
(Harding, 1992). The molecular weight data of the a and the major
components

of

the

p

fractions

correspond

exactly

to

the

theoretical molecular weights derived from the known sequences
of these crystallins with the exception of PB3 which is currently
being investigated in more detail (Kilby, Sheil and Truscott,
unpublished work). The aA and pH crystallin mass spectra also
gives the first evidence that there is a serine loss from these two
crystallins since the spectra of the a A and pH fractions showed
peaks at 19747 Da and 23122 Da consistent with loss of serine (87
Da) from aA and PB2 respectively. These peaks were absent from
the electrospray mass spectra of the foetal lens proteins which is
a strong

indication

Takemoto

(1992)

of an age-related
have

also

change. Emmons and

recently

demonstrated,

by

combination of tryptic digest method and mass spectral analysis,
that the loss from a A is indeed the C-terminal serine. Thus this
work focused primarily on the analysis of pB2 crystallin.
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5.2.

Preparation

loss of (3B2

of

the

C-terminal

model

experiment

for

the

serine

extension

In order to collect the desired HPLC peaks which correspond
to the trypsin cleaved C-terminal extension polypeptides and
serine loss C-terminal extension polypeptides, a model sequence
of pB2 crystallin C-terminal extension (M-Q-W-H-Q-R-Q-A-F-H-PS-S

192-204)

was

custom-synthesised

by Auspep Pty. Ltd.

(Victoria, Australia). The purity of this polypeptide is HPLC grade,
and it was synthesised by using a standard solid-phase synthetic
methods. In this model peptide Metl92 and Gin 193 are not part
of the flexible C-terminal extension of pB2 crystallin.
Carboxypeptidase A was used to cleave serine (204) from
the model polypeptide. This was followed by tryptic digestion to
split this peptide at Arg (197). The experimental procedure
described in chapter 7 allowed for half the amount of peptide to
be digested with carboxypeptidase A, with the aim of generating
two desired polypeptides corresponding to the serine loss and
normal
crystallin.

C-terminal

residues

cleaved

by

trypsin

from PB 2

The digested synthetic polypeptide solution was then

injected onto the HPLC and separated under the conditions
described in chapter 7. The HPLC peaks were collected, freeze
dried and sent for amino acid analysis.

CE analysis was also

carried out on these freeze dried polypeptide samples
The HPLC profiles for the synthetic peptide M-Q-W-H-Q-RQ-A-F-H-P-S-S (192-204) before and after carboxypeptidase A
and trypsin digestion are shown in Fig.s 13 and 14.
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Fig. 13. The HPLC profile of synthetic peptide before
trypsin digestion.

r-.

ir:..
(N
Ûh1 0_

,: 0

Fig 14. The HPLC profile of the polypeptide after
carboxypeptidase A and trypsin digestion.
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The amino acid analysis results are shown in Table 1.

Peak Area

Peak Area

PI (serine loss)

P2 (normal)

P1/P2

Serine

6718016

13628377

0.49

Glycine

7718295

8660225

0.96

Histidine

1254988

1300167

0.94

Alanine

5657275

5994894

0.91

Phenylalanine

2394002

2646325

0.90

T a b le 1. A m in o acid an alysis o f H P L C fraction o f P I (C -term inal residue w ith
ser in e lo s s ) and P 2 (n orm al se q u e n c e o f C -term in al r e sid u e). T h e num bers in the
colu m n are am in o acid p eak area.

The HPLC profile showed that after the carboxypeptidase A
and trypsin digestion, the synthetic polypeptide had been cut into
three parts.

The amino acid analysis results show that the HPLC

peak 1 corresponds to the serine loss C-terminal peptide and the
peak 2 is the normal sequence C-terminal peptide of the pB 2
crystallin. The third peak is the N-terminal tryptic peptide from
the synthetic peptide.

5.3.

Preparation

loss of ocA

of

the

C-terminal

model

experiment

for

the

serine

extension

A model synthetic polypeptide for the sequence of the a A
C-terminal extension (S-R-E-E-K-P-S-S-A-P-S-S

162-173) was

also synthesised by Auspep Pty. Ltd. This peptide was treated
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with carboxypeptidase A and trypsin in the same way as the
model peptide for (3B2 (see chapter 7). However, despite repeated
attempts at the tryptic digestion (including digestion at 37°C
overnight), it was not possible to cleave this peptide at Argl63,
perhaps because of steric hindrance by the two adjacent glutamic
acid residues.
Two

alternative

approaches

using

an

arginine-specific

protease from mouse submaxillary glands (Endoproteinase ArgC), and staphylococcal protease (strain V8, EC 3.4.21.19) to try a
cleave at the glutamic acid residues were also unsuccessful.
The failure to prepare the model tryptic digested a A Cterminal polypeptides (serine loss and normal sequence) made it
difficult to continue with this aspect of the work since the tryptic
digest a A crystallin resulted in a complex HPLC profile, in which
it was not possible to decide which two peaks corresponded to the
serine loss and normal sequence of C-terminal extensions.

5.4.

Tryptic

cleavage

of the

C-terminal

extension

of pB 2

cry sta llin

With limited tryptic digestion, the C-terminal of pB 2
crystallin can be removed at Argl97 resulting in a seven amino
acid polypeptide (Berbers et al., 1984). The tryptic digestion of
foetal and aging pB2 crystallin in this experiment used the
method of Allen (1990). The detailed method for the C-terminal
cleavage is described in 7.4.2.
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During

the

digestion,

timed

samples

were

taken

and

monitored by HPLC analysis. After examining the results, the
optimal trypsin digestion time was determined to be 10 minutes.
Within this time, rapid digestion preferentially occurred at Arg
197 and no globular domain digestion was observed. This was
also noted by Berbers et al. (1984)

5.5. pB2

C-terminal

residues

purification

by

HPLC

An optimized HPLC separation (see 7.5.3. for detail) was
used for the purification of the tryptic pB2 C-terminal residues.
Peaks with the same retention times as the model serine loss and
normal C-terminal polypeptides were collected and freeze dried
for CE and electrospray MS analysis.
The HPLC profiles of purification of C-terminal residues of
tryptic digest (3B2 crystallin

r

Fig 15. HPLC chromatogram from aged bovine lens pB2 crystallin C-terminal
residues.
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<N

CU

Fig 16. HPLC chromatogram from foetal bovine lens pB2 crystallin C-terminal
residue.
These
ageing

two

HPLC

pB2 crystallin

chromatogram s
has both

clearly

serine loss

show

that the

(P I) and normal

sequence (P2) C-terminal residues while the foetal pB2 crystallin
has the normal sequence (P2) C-terminal residue only. Because
there was some overlap of the peaks in figure 15, however, the
fractions collected for CE and MS analysis were not completely
p u re.
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5.6.

Identification

and

normal

crystallin

by

of

the

C-terminal

serine
residues

loss
of

C-terminal
bovine

residues

lens

pB 2

CE.

Figure 17 shows the capillary electrophoresis profile of the
synthetic peptide model for pB2 crystallin which has been
digested

with

both

carboxypeptidase

A

and

trypsin.

This

electrophoregram was obtained using a 0.1M tricine and 0.02M
morpholine buffer (pH 8.1) and

10 kV applied voltage. In

separate

in

experiments

described

chapter

7

these

were

determined to be the optimum conditions for the separation of
the small peptides
In figure 17, the peak at 20.0 minutes is due to the G-A-FH-P-S-S (198-204) peptide, the peak at 17.4 minutes from the
corresponding serine loss peptide G-A-F-H-P-S (198-203), the MQ-W-H-Q-R

(192-197)

peptide

resulting

from

the

tryptic

digestion appears at the retention time 16.5 and there is a large
peak due to the tryptic digestion buffer at 16.9 min. The very
high resolution of the CE allows the two peaks of interested to be
well separated compared to the HPLC separation.
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Fig. 17. CE profile of the trypsin digested synthetic PB2 C-terminal model
polypeptides sample. The numbers above the peaks are retention times in minutes. The
peptides were shown to be G-A-F-H-P-S-S (20.0), G-A-F-H-P-S (17.4) and M-QW-H-Q-R (16.5). The largest peak (16.9) is due to the NH4 HCO3 (tryptic digestion
buffer).
Using the same CE conditions, the HPLC-purified pB2 Cterm inal residues peaks (HPLC PI

and P2) obtained from the

tryptic digest of pB2 crystallin were also analysed by CE.
The CE profiles of the HPLC PI and P2 are shown in Fig. 18
and 19.
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Fig 18. CE profile of serine loss C-terminal residue of PB 2
crystallin (HPLC PI).

Fig 19. CE profile of normal sequence C-terminal residue of
PB2 crystallin (HPLC P2).
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In Fig. 18 and Fig. 19, both the serine loss and normal
sequence

C-term inal

electrophoregram at

residues

appeared

on

the

same

16.8 and 19.7 min respectively. This is

because these two peptides were not well separated by HPLC (see
Fig. 15). However, in Fig. 18, which corresponding to the HPLC PI,
the serine loss C-terminal residue is the most abundant species
and in Fig 19, which corresponding to the HPLC P2 the normal
sequence C-terminal residue is the most abundant.

5.7.

Identification

and

normal

crystallin

The

by

two

of

the

C-terminal

serine
residues

loss
of

C-terminal
bovine

lens

residues
pB 2

EMS.

HPLC fractions

(PI

and P2)

obtained from

purification of the trypsin digested pB2 crystallin were also
analysed by electrospray mass spectroscopy using the conditions
described in the general procedures (see 7.1.5 for detail).
The electrospray mass spectra are shown in Fig. 20 and 21
for HPLC PI and P2 respectively. In these spectra, Fig. 20 gives a
(M+H)+ peak at 615.2 Da and Fig. 21 gives a (M+H)+ peak at 702.3
Da which corresponds to the trypsin cleaved serine loss (G-A-F-HP-S MW=614.8) and normal sequence (G-A-F-H-P-S-S MW=701.9)
C-terminal residues of PB2 crystallin respectively. As with the CE
results, there is some small amounts of each of the peptides in
both spectra but the most abundant species are consistent with
the CE and HPLC results. The peak at 615 Da was not present in
HPLC fraction collected from tryptic digested foetal 0B2 crystallin.
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5.8.

Summary

Thus all the available evidence obtained from the combined
MS, HPLC and CE data indicates that there is in fact an age-related
serine loss from |3B2 crystallin, which in turn indicates that there
is an unknown enzyme with activity like that of carboxypeptidase
A in the bovine lens.

Fig.

20.

Electrospray

Mass

Spectrum

of

trypsin

serine loss C-terminal residue of bovine (3B2 crystallin

cleaved

Fig.

21.

Electrospray

Mass

Spectrum

of

trypsin

cleaved

normal sequence C-terminal residue of bovine (3B2 crystallin

59

CHAPTER 6
CONCLUSION

Thus, in the first part of this project, of the three attempts to
synthesis 3-hydroxykynurenine glucoside, only the third method
involving

directly

coupling

3-hydroxykynurenine

with

acetobromoglucose successful, however, this method is limited for
large

scale

synthesis

because

of

the

high

cost

of

3-

hydroxykynurenine (A$ 900/per gram).
Therefore, in future work arising from this project, some of
the information derived from the first method could be used to
improve

the

yield

of

3-hydroxykynurenine

glucoside.

For

example, in method one, using blocked 3-hydroxykynurenine is a
good design since in the third method, which used unblocked 3hydroxykynurenine, during the coupling the acetobromoglucose
could be attached to 3-hydroxykynurenine from at least three
positions as evidenced by the presence of five by-products found
when purifying the glucoside synthesised from the third method.
This may be reduced if the blocking strategy were to be
incorporated into the third method with a subsequent increase in
yield.
Secondly, of the three synthetic methods, only method 2 has
the

possibility

for

synthesis

of

a

large

amount

of

3-

hydroxykynurenine glucoside, because it does not involve using

3-hydroxykynurenine

as a starting material, so, it would certainly
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be worthwhile to try and improve the yield of the coupling
reaction which limited work on this method.
In the second phase of this project, the loss of serine from
the

C-terminus

of PB2

crystallin

was

confirmed

using

a

combination of HPLC, CE and MS (before and after tryptic
digestion) analysis. No serine loss was observed at the C-terminal
extension of foetal PB2 crystallin by HPLC and MS. Further, mass
spectrometry results for a A crystallin serve to confirm Emmons
and Takemoto's (1992) observation of a similar age-related serine
loss from this crystallin which also has the X-P-S-S sequence (KP-S-S-A-P-S-S) at the C-terminal extension. The evidence of
serine loss from the C-terminal extensions of the a A and PB 2
crystallin

in

aged

bovine

lens

suggests

that

there

is

a

carboxypeptidase A like proteinase present in the bovine lens
that digests the bovine a A and PB2

crystallin

C-terminal

extensions gradually throughout life. The origin, structure and
function of this proteinase is not clear, however, this C-terminal
serine cleavage may affect lens function. For example, the Cterminal extensions of a A and pB2 crystallin act as attachment
sites for oligomers formation or for binding to other cellular
components

(Berbers, et al., 1984), and the cleavage of serine

may prevent the formation of crystallin aggregates and hence
lead to some loss of lens opacity.
Future work in this area could include extending this
approach using mass spectrometry, HPLC and CE to look for futher
evidence of enzymatic cleavages of crystallins in aged and
diseased human lens.

CHAPTER 7
GENERAL PROCEDURES

7.1.

General

7.1.1

Melting

procedures
Points

(m.p.)

Melting points were determined on a Reichert hot stage
apparatus and are uncorrected.
7.1.2.

Ultraviolet

(UV)

Spectra

Ultraviolet spectra were recorded on a Shimadzu UVVisible Recording Spectrophotometer, Model UV-265.
7.1.3. l H

Nuclear

Magnetic

Resonance

(NMR)

Spectra

lH NMR spectra were recorded on a JEOL FX 90Q Fourier
Transform NMR Spectrometer operating at 90MHz, or a Varian
Unity 400 NMR Spectrometer operating at 400MHz. The
spectra were measured in CDCI3 unless otherwise stated,
relative to tetramethylsilane (0.00 p.p.m.). Each signal was
described

in

terms

tetramethylsilane,

of

chemical

multiplicity,

shift

intensity,

in

p.p.m.

coupling

from

constant

(Hz) and assignment in that order with the use of the following
abbreviations: s, singlet; d, doublet; t, triplet; q, quartet; and m,
m ultiplet.
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7 .1 .4 . l ^ c

Nuclear

Magnetic

Resonance

(NMR)

Spectra

13C NMR spectra were recorded on a Varian Unity 400
NMR Spectrometer operating at 100 MHz.
7.1.5

Mass Spectra

(MS)

Fast atom bombardment mass spectra were recorded on
a VG

12-12 mass spectrometer using a glycerol matrix.

Electrospray mass spectra were recorded on a VG Quattro
triple quadrupole mass spectrometer (VG Biotech, Altrincham,
Chesire, England). The flow rate was 5ml/min and the source
temperature

was

65°C. Samples were dissolved in 50:50

acetonitrile:water at a concentration of about 200 pmol/ml.
7.1.6.

Thin

Layer

Chromatography

(T.L.C.)

Thin layer chromatography was carried out on the
5x7.5cm aluminium backed silica gel 60 plates F254 (MERCK).
7

#1 %
7 #

High

p e r fo r m a n c e

L iquid

C h ro m a to g r a p h y

(HPLC)

(i) For purification of 3-hydroxykynurenine glucoside
High Performance Liquid Chromatography was carried
out on an ICI HPLC System, employing an Activon GOLDPAK
C l8 column packed with SPHERISORB 5 ODS2 (25 x 0.46 cm).
The isocratic mobile phase consisted of 20mM sodium acetate
and 20mM acetic acid buffer, at pH4.5. The flow rate was
0.6ml/min. Detection was carried out employing a Knauer
variable

wavelength

monitor,

set

at

365nm.

The
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chromatograms were recorded with a Shimadzu C-R6A data
processor.
(ii)

For Peptides
High

Perform ance

Liquid

Chromatography

was

performed on a Waters HPLC system, employing a Waters
Bondapak C-18 column. The mobile phase consisted of solvent
A: water with 0.05%TFA (trifluoroacetic acid) , and solvent B:
50% acetonitrile in water with 0.05%TFA. The solvent system
employed consisted of gradient elution from 100% A to 59% B
in 60 min. The flow rate was 0.8mL/min. Detection was
carried out employing a Waters absorbance detector Model
441, at either 229 or 280 nm.
7.1.8.

Capillary

Electrophoresis

(CE)

Capillary electrophoresis was carried out on the ISCO
model 3850 CE system, with a fused silica ISCO CE capillary
column 50mm x 84cm. The length from injector to detector
was 49 cm. The buffer system consisted of 0.1 M tricine and
0.02 M morpholine, pH 8.1. The voltage and current used
during the electrophoresis were 10 kV and 11mA respectively
and results were recorded on a Shimadzu C-R6A Chromatopac
data processor. The detector wavelength set at 210 nm.
7.1.9.

Amino

Acid

Analysis

(AAA)

Amino acid analysis was performed on a ICI AAA
system, which uses a ICI 1150 HPLC pump and a 3 mm ODS-2
Spherisorb HPLC column (150 x 4.6 mm ID). Two detectors
were used on this system, a Knauer UV-Visible photometer
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with

the

wavelength

programmable

set

wavelength

at

254nm

and

fluorescence

an

ICI-1250

detector

set

at

ExX=262 nm, EmA.=314 nm. The binary gradient system
employed 18% B to 99% B in 24 min. Buffer A: 20 mM
am m onium

d ih y d ro g en -o rth o rp h o sp h ate(p H 7 ): m ethanol

(85:15). Buffer B: 90% acetonitrile in water. The flow rate was
l.Oml/min. An IBM computer was used as a recorder using the
ICI DP 800 chromatography management system. The samples
were prepared by using 9-fluorenylmethylchloro-formate (FMOC) as the precolumn derivatisation reagent. (Haynes et al.,
1991).
7.1.10.

General

Methods

Evaporation of the organic solvent refers to removal the
solvent on a Buchi rotavaporator (water aspirator pressure),
followed by the removal of the last trace of solvent with a
high vacuum pump.
7.1.11.

Chemicals

The

3 -hydroxykynurenine,

3-hydroxyacetophenone,

tricine and morpholine were obtained from Sigma Chemical
Company

and

used

without

further

purification.

Ethyl

nitroacetate was obtained from Aldrich. Peptide A (M-Q-W-HQ-R-G-A-F-H-P-S-S 192-204) and peptide C (S-R-E-E-K-P-S-SA-P-S-S 162-173) were purchased from Auspep company.
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7.2. METHODS AND SYNTHESIS FOR THE COMPOUNDS OF
SCHEME 1

7.2.1

P reparation

of

N -T FA -3-h ydroxykyn u ren in e

methyl

ester

3-Hydroxykynurenine (22.4mg, O.lmM) was added to 10ml
of a stirred 10% thionyl chloride methanol solution. The solution
was stirred at room temperature for 15 hr. TLC, with BAW
(Butanol: Acetic acid : Water=4:2:l) as developing solvent, showed
the appearance of a new UV active spot (Rf=0.6) and no starting
m aterial

(3-hydroxykynurenine

Rf=0.5).

The

evaporated and the residue was redissolved in

10

solvent

was

ml methanol.

Triethylamine (20.2mg, 0.2mM) and methyl trifluroacetate (25.6
mg, 0.2 mM) were added whilst stirring and the solution was
stirred at room temperature for a further 10 hr. The methanol
was then removed under vacuum. The residue was passed though
a silica column with chloroform to give the required N-TFA-3hydroxykynurenine methyl ester

(20

mg, 60% yield).

TLC (B:A:W=4:2:1): Rf=0.8
MS: mw=334
lH NMR (CDCI3): 5 7.51 (d, 1H, J =8 NH), 7.20 (d, 1H, J=8, ), 6.77 (d,
1H, J=8), 6.43 (t, 1H, J=8), 5.36 (s, 2H), 4.86 (m, 1H), 3.81-3.43 (m,
2H), 3.71 (s, 3H).

66
7.2.2

P rep a ra tio n

pyranose

of

2 ,3 ,4 ,6 -tetra -O - b e n z y l - D - g l u c o -

(tetrabenzylglucose)

This compound was prepared according to the method of
Glaudemans et al. (1972).
125g of powdered potassium hydroxide (2.23M) and 25g
methyl-a-D-glucopyranoside (129mM) were added to a

75ml

dry

dioxane. While keeping the mixture boiling and stirring, 159ml of
benzyl chloride was added in dropwise fashion over a 40min
period and the same conditions were maintained for a further 30
min to complete the reaction. Then the dioxane was distilled out
slowly over a 3 hr period. The residue was cooled and the crystals
formed

were

dissolved

with

sufficient water (500ml).

This

aqueous solution was extracted with 300ml ether. The separated
ether phase was then washed twice with water (200ml each time)
and dried in lOg anhydrous sodium sulphate. The dried ether
phase was filtered though a layer of activated charcoal and then
the ether was removed under vacuum. After the benzyl alcohol
and dibenzyl ether, formed in the reaction, were removed on a
200 °C oil bath under vacuum pump, 67.5g of crude product was
obtained like light-yellow syrup (95% yield).
The syrup was dissolved in 1.25 L of hot glacial acetic acid
on a steam bath. While boiling, 270ml hot 1M sulphuric acid was
added. Then the mixture was kept on a steam bath for 2 hr,
followed by addition of another 270ml of boiling 1M sulphuric
acid. After the same conditions were maintained for 24 hr, the
mixture was cooled and poured into 10L of water. The water
solution was kept at 25°C for 2 days. After this time, the water
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was filtered out and the residue was dried and recrystallised from
methanol.

In the end, 48.7g pure

2 ,3 ,4 ,6 -tetra-0 -b e n z y 1-D-

glucopyranose white crystals were obtained with 70% yield.
M.P.: 143°C (literature 143°C).
1h NMR: (CDCI3) 8 7.38-7.22(m,4x5H), 5.23, 5.22 (d, 1H, Cl, J=3.6),
4.95-4.46 (m, 8H, 4 x O-CH^-Ph. and 2H, C6), 3.65-3.56 (m, 4H C-2,
C-3, C-4, C-5).
7 .2 .3

C o u p lin g

ester

with

of

N -T F A -3 -h y d r o x y k y n u r e n in e

methyl

2 ,3 ,4 ,6 -tetra -o -b en zy l-D -g lu co p y ra n o se

This preparation followed the method of Tsutsumi et al.
(1981)
T etrabenzylglucose
carbodiimide

(280mg,

(540mg,

1 mM)

ImM );

and copper(I)

dicyclohexyl
chloride

(lmg,

0.0ImM) were added to 5 ml chloroform. The solution was stirred
at room temperature for

2

days, after which time the copper (I)

chloride was washed out, first with 0.5 M aqueous ammonia
solution (10 ml), and then with water(10 ml). The organic phase
was dried with sodium sulphate. To this stirred chloroform
solution,

N-TFA-3-hydroxy kynurenine

methyl

ester

(17mg,

0.05mM) in 1 ml chloroform was added. The solution was kept
stirring for another

2

days at room temperature after which time

the solution was concentrated to

1

ml, and put though a silica

column with chloroform as developing solvent to give N-TFA-3hydroxykynurenine

methyl ester tetrabenzylglucoside

70% yield) as a yellow white solid.
TLC (B:A:W:=4:2:1): Rf=0.7

(30.5mg,

68

! h NMR (CDCI3 ): 5 7.31 (s, 5x5H), 6.6-6.5 (m, 3H), 5.16 (d, 1H, J=8),
4.91-4.55 (m, 4x2H), 4.80 (m, 1H), 4.00 (m, 4H), 3.76 (s, 3H), 3.80
3.60 (d, 2H, J=18).

7.2.4

P reparation

ester

glucoside

of

N-TFA -3-hydroxykynurenine

N-TFA-3-hydroxykynurenine

methyl

ester

methyl

tetrabenzyl-

glucoside (17 mg, 0.02 mM) was added to 10 ml of glacial acetic
acid which was dried over anhydrous cupric sulphate. Palladium
on activated carbon

(2

mg,

10%)

was added as a catalyst and the

solution was stirred under a hydrogen atmosphere for 15 hr. The
catalyst was filtered out and the acetic acid was removed under
vacuum.
The iH NMR spectrum revealed the débenzylation reaction was
unsuccessful.
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7.3. METHODS AND SYNTHESIS FOR THE COMPOUNDS OF
SCHEME 2

7.3.1

P re p a r a tio n

of

3 -h y d ro x y -2 -n itro a c eto p h en o n e

Preparation according to the method of Butenandt et al.
(1957).
3-Hydroxyacetophenone (5g, 0.037mol) was dissolved in dry
glacial acetic acid (30 ml) and acetic anhydride (4g, 0.039 mol)
was added dropwise over 15 min at 10°C. The reaction mixture
was stirred for

10

min and thereafter treated with cupric nitrate

trihydrate (10g, 0.041 mol). Then the reaction mixture was cooled
to 0°C and kept at this temperature for 2 hr, after which time the
reaction mixture was poured into ice water (100ml). The solid
formed was removed by filtration and dried, then redissolved in
hot

benzene

(150ml).

The

mixture

was

recrystallised

by

concentrating to 70 ml, cooling slowly and then kept overnight to
precipitate

the

undesired

mother liquor was further

3 -hydroxy-6-nitroacetophenone. The
concentrated to approximately 10 ml to

give the required isomer. The compound was redissolved in
chloroform and passed through a silica column with chloroform as
developing solvent to give pure
(0.54g,

8. 12%

M.P.: 136 °C

3-hydroxy-2-nitroacetophenone

yield) as a white yellow solid.

70

l U NMR (CDCI3): d 7.68-7.50 (d,d, 1H, J=9, C5), 7.26-7.14 (d,d, 1H,
J5H-4H=9, J6H-4H=1.8, C4 ), 6.87-6.77 (d,d, 1H, J5H-6H=7.2, J4 H6H=1.8, C6), 2.51 (s, 3H, ).
7.3.2

Preparation

of

2,3,4,6-tetraacetyl-a-glu cop yran osyl

bromide.

Preparation according to the method of Vogel’s Textbook of
Practical Organic Chemistry, (Furniss, et a l , 1989. see page 647
648).
20ml of acetic acid (212mM) was cooled to 4°C and while
stirring, 0.12ml of 60% perchloric acid was added as a catalyst.
After

warming

to

the

room

temperature,

5g

(28mM)

dry

powdered d-(+)-glucose was added in several portions while the
temperature was maintained between 30-40°C. The mixture was
cooled to 20°C and 1.6g (20mM) red phosphorus was added. In
the following step, 2.9ml of bromine (9.1 g, 113mM) was added
dropwise at a rate so that the temperature did not rise over 20°C.
Lastly, 1.8ml of water was added over a period of 30 min. The
reaction mixture was stirred at room temperature for about 2 hr,
then diluted with 15ml dichloromethane. After this the mixture
was transferred to a separating funnel, washing twice with iced
water. The dichloromethane layer was drained to a big beaker
containing
hydrogen

a

150ml

carbonate.

saturated

solution

When the evolution

of

aqueous

sodium

of carbon dioxide

subsided, the dichloromethane layer was separated and dried in
2g powdered silica gel. After filtering out the silica gel and
removing

out

the

dichloromethane,

the

crude

product

was
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recrystallized

twice

from

hexane-ether

(50:50),

the

pure

acetobromoglucose was obtained as white crystals.
MP: 87°C (literature 88-89 °C).
iH NMR (CDC13): 5 6.63, 6.58 (d,lH,), 5.67-5.46 (t, 1H), 5.26-5.05
(t,lH), 4.9-4.75, (d,d, 1H), 4.28 (m, 3H), 2.09, 2.04, 2.03 (s,s,s,
4xCOCH3).

7.3.3

C oupling

of

acetobrom oglucose

with

3-hydroxy-2-

n itro a c e to p h e n o n e .
Potassium carbonate (0.77g, 5.6 mM) was added to a stirred
solution of 3-hydroxy-2-nitroacetophenone (0.5g, 2.8mM) in dry
acetone

(5mL)

which

was

followed

by

adding

dropwise

acetobromoglucose (2.3g, 5.6mM) in dry acetone solution (5ml).
The mixture was then stirred for 2 days at room temperature,
after which time it was filtered to remove salt. Removal of solvent
and

recrystallisation

from

ether

afforded

pure

3-hydroxy-2-

nitroacetoglucoside as a white solid.
M.P.: 168°C.
! h NMR: (CDCI3) 5 7.53 (s.,3H, C-4, C-5, C-6), 5.21 (m, 4H, C -l\ C-2’,
C-3', C-4'), 4.22 (d, 2H, CH2OAC, J=3.8), 3.89 (m, 1H, C-5’), 2.56 (s,
3H), 2.11,2.07, 2.02, 2.01 (s,s,s,s,. 4 X COCH3).
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7.3.4

Preparation

phenone

of

a-Bromo-2-nitro-3-hydroxyaceto-

t e t r a a c e t o g l u c o s id e

An excess of dioxane dibromide (1.2 equiv) was added to a
solution

of

2-nitro-3-hydroxy acetophenone

tetraacetoglucoside

( 200mg) in dichloromethane ( 10ml), followed by ether (15ml).
The solution was stirred for

6

hr. After TLC showed no more

starting material, the solution was diluted with dichloromethane
(50ml),

and

washed

twice

with

saturated

sodium

hydrogen

carbonate solution (40ml). The organic layer was dried (by
Mg SO 4 ) and the dichloromethane was removed at 30-40° C .
Recrystallisation
hydroxy
(150mg,

from

acetophenone

66%

ethanol

obtained

tetraacetoglucoside

a-bromo-2-nitro-3as

a white

solid.

yield).

M.P.: 144.5-145°C.
1h NMR (CDCI3): 5 7.56 (m, 3H), 5.01-5.27 (m, 4H), 4.34 (d,lH,
J=12.4Hz), 4.30 (1H, d, J=12.4Hz), 4.24 (d, 2H, J=3.7Hz), 3.85 (d,d,d,
1H, J=3.7, 3.7, 9.6Hz), 2.13, 2.09, 2.04, 2.03 (4xs, 12H).
13c NMR CDCI3): 5 188.93 (C), 170.44 (C), 170.11 (C), 169.30 (C),
169.26 (C), 148.59 (C), 141.11 (C), 131.40 (CH), 128.72 (CH),
124.35 (CH), 124.08 (CH), 100.34 (CH), 72.41 (CH), 72.08 (CH),
70.28 (CH), 67.96 (CH), 61.62 (CH2 ), 30.83 (CH2 ), 20.44-20.67
(CH3).
Microanalysis: C22H24BrNOl3. Found: C:44.54, H:3.96, N:2.37%
Required: C:44.75, H:4.07, N:2.37%

73

7.3.5

Coupling

a-bromo-2-nitro-3-hydroxyacetophenone

tetraacetoglucoside

1.5

with

e t h y ln itr o a c e ta te

equivalents of ethylnitro-acetate (40mg, 0.3mM) was

added to 1ml of dry DMF, followed by 1.0 equivalent of NaH
(lOmg, 0.2mM). The solution was stirred at room temperature for

10

min under a nitrogen atmosphere, after which time a-brom o-

2-nitro-3-hydroxyacetophenone tetraacetoglucoside (118 mg,

0.2

mM) in 1.0 ml dry DMF was added followed by 1.0 equivalent of
AgC104 (42mg, 0.2mM)- The solution was stirred for 30 min, after
which time the TLC showed no starting material remained, and
several UV reactive spots had appeared on the TLC. The solution
was diluted with

10

1M

organic

HC1.

The

10

ml dichloromethane and washed with
phase

was

dried

by

MgS04

ml
and

dichloromethane was evaporated. The residue was purified on a
preparative

TLC

plate

by

developing

with

ethyl

acetate/

dichloromethane (1:1). The spots were collected for NMR analysis.
The NMR data showed the coupling reaction was unsuccessful.
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7.4. METHODS AND SYNTHESIS FOR THE COMPOUNDS OF
SCHEME 3

7 .4.1.

P rep a ra tio n

of

3 -h y d ro x y k y n u re n in e

acetobromo-

glucoside.

3-hydroxykynurenine (9mg, 0.03mM) was dissolved in 5 ml
sodium

carbonate/sodium

hydrogen carbonate

buffer (0.1 mM,

pH10.5). The solution was stirred at room temperature for about
10 min, after which time acetobromoglucose (41mg, O.lmM) in 5
ml acetone was added dropwise over 4 hr under nitrogen. The
solution was then stirred for another 4 hr. A new UV reactive spot
appeared on TLC suggesting that this coupling reaction gives 3hydroxykynurenine

acetobromoglucoside.

MS (electrospray): MW=554 (MH+=555)
TLC (BAW) Rf=0.6

7.4.2.

Preparation

of

3-hydroxykynurenine

glucoside.

Sodium hydroxide (400 mg, 10 mM) was added to the
solution of 3-hydroxykynurenine acetobromoglucose. Then the
solution was stirred for 3 hr at room temperature. After which
time the solution was neutralised with concentrated hydrochloric
acid and the acetone was removed under vacuum. The remaining
solution was passed though an Alltech Maxi-clean Cl 8 cartridge
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and eluted with water. The fraction collected was dried on a
Speedvac freeze drier and redissolved in the 20 mM HPLC buffer.
HPLC was performed as described in general procedures (g) and
the 15 min peak (3-hydroxykynurenine glucoside) was collected.
After the sample was dried on the Speedivac freeze drier, it was
chromatographed

through

a Sephadex column equilibrated

in

water (35 X 1.2cm; flow rate 5 ml/hr) for purification and to
remove the HPLC buffer salt. The water was evaporated under
vacuum to give pure 3-hydroxykynurenine glucoside

(3

mg

20%

yield) as a brown-yellow solid.
TLC (BAW); Rf=0.2
MS (electrospray): Theoretical MW=386 (MH+=387)
*H NMR (D20): 5 7.48, 7.47 (d, 1H), 7.18, 7.16 (d, 1H), 6.61, (t, 1H),
4.90, 4.89 (d, 1H), 3.78, 3.74 (d,d, 1H), 3.61, 3.58 (d,d,2H), 3.46 (m,
4H), and 3.38, 3.36 (d,d, 2H).
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7.5. METHODS FOR TRYPSIN AND CARBOXYPEPTIDASE A
DIGESTION.
7 . 5 . 1 C a r b o x y p e p tid a s e
polypeptides

A

Polypeptide

(model

A

and

experiment

tr y p sin
for

pb2

d ig estio n
crystallin)

A (M-Q-W-H-Q-R-Q-A-F-H-P-S-S

192-204),

corresponding to the C-terminus of bovine PB2 crystallin, (lmg,
0.63mM) was dissolved in 1ml 0.1 M NH4 H CO 3 , O.lmM CaCl2
buffer (pH=8.1) and carboxypeptidase A (1% by weight of the
polypeptide A) in 2M NH4 H C O 3 was added. Before use, the
carboxypeptidase A was washed twice with water to remove
contaminating amino acids and dissolved in 10ml 2M NH4 HCO 3 .
The mixture was then incubated in a 37°C water bath for 1 hour.
After that period TPCK treated trypsin purchased from Sigma (1%
by weight of the polypeptide A) in O.lmM HC1 was added. The
mixture was incubated at 37 °C again for 10 min. Lastly, 1ml 5%
TFA water was added to stop the enzyme digestion. The digested
polypeptide A solution was kept in the freezer (-20 °C) until HPLC
and CE analysis.

7.5.2.

Trypsin

digest P B 2 c r y s t a l l i n

4mg of pB2 crystallin was dissolved in 1ml of 0.1 M
NH 4 HCO 3 , O.lmM CaCl2 buffer (pH=8.1), followed by addition of
TPCK treated trypsin (1% by weight of the pB2 crystallin) which
was in O.lmM HC1. The mixture was incubated in a water bath at

37 °C

for 10 min. After which time, 1ml 5% TFA water was added

of
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to stop the tryptic digest. The mixture was transferred to two
small Eppendof tubes and centrifuged for 10 min to remove the
precipitated protein. The supernatant was collected and kept in
freezer (-20 °C) for HPLC separation.

7.5.3.

Optimization of HPLC conditions for the tryptic pB 2

C -term in al

residues

purification

A C-18 reverse phase HPLC column was chose for the pB2 Cterminal

residue

purification,

acetonitrile

and

water

were

selected as the mobile phase while different gradient programme
were

tested.

The optimization is only concentrated

on the

selection of gradient programme. The optimal HPLC conditions are
as follows:
Buffer A: Milli Q water with 0.05% TFA (trifluoroacetic acid).
Buffer B: 50% acetonitrile:50% Milli Q water with 0.05 %TFA
Gradient programme: 100% buffer A to 50% buffer B in 60
minutes.
Flow rate: 0.8ml/min
Detector wavelength: 229 or 280nM.
Each time the HPLC was turned on, a standard sample of
carboxypeptidase A and trypsin digested synthetic model Cterminal

polypeptide

was

used

to

calibrate

the

Purification of trypsin digested foetal and old pB2

column.
crystallin

samples was then carried out. Peaks with the same retention
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times as the model serine loss and normal sequence of the tryptic
C-terminal polypeptides were collected and freeze dried for CE
and electrospray MS analysis.

7.5.4.

O ptim ization

term inal

In

peptides

this

of

CE

Conditions

for

tryptic

C-

Analysis

experiment,

an

ISCO

model

3850

capillary

electrophoresis system with a fixed length ISCO CE capillary
column (50mm x 84cm) was used. The optimization of CE
conditions is concentrated on the selection of electrolyte buffer
and adjustment of suitable high voltage value.
Five peptide samples (1. L-Phe-Ala-Gly-Gly; 2. L-Ala-AlaAla; 3. N-Acetyl-Ala-Ala-Ala; 4. Tyr-Gly-Gly and 5. Hexaglycine)
were used as standard for the selection of electrolyte buffer. Four
electrolyte buffer system were tested;
1. 40mM ammonium acetate buffer, adjust pH to 6.5 with
acetic acid.
2.

20mM Na2HP04/NaH2P04

buffer pH=8;

3. 40mM Tri-sodium citrate buffer, adjust pH to 7 with
80mM citric acid.

4.

0.1M Tricine and 0.02M morpholine buffer, adjust pH to

8.1 with 0.1M HC1 or 0.1M NaOH.
While test each electrolyte buffer with the five peptides,
different high voltage from 10 to 30 kV were tried. In the end,
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the optimum CE conditions for analysis of C-terminals residue
were:
Electrolyte Buffer: 1M Tricine and 0.02M morpholine buffer,
adjust pH to 8.1 with 0.1M HC1 or 0.1M NaOH;
High Voltage: 10 kV;
Detector Wavelength: 210 nM.
The analysis was performed at room temperature.

ppm

lH

NMR

ester

spectrum

of

N -T F A -3-hydroxykynurenine

m ethyl

sequence*
sldlh

ppm

IH

NMR

spectrum

of

2 .3 ,4 ,6 -tetra-o -b en zy l-g lu co p y ran o se.

J
flCOUlSIlIOM

lH

NMR

spectrum

of

;2-nitro-3-hydroxyacetophenone.

otf- " M Z / s p I J / o u f i d /

NT

*H NMR spectrum of 2,3.4, 6-tetraacetyl-a-glucopyranosyl
bromide.

ZT

O.

pi
pulse
tequencel
aldlh

ppm

I H NMR spectrum of ?-nitro-3-hydroxyacetophenone
tetraacetoglcoside.

uicM

NMR spectrum of ex-bromo-2- n i t r o-3 - h y d r o x y a c e t o p h e n o n e
tetraacetoglucoside

w

3

womsinnow

Cr

rr

m 0 m m

T> -i

1H

NMR

spectrum

of

3-hydroxykynurenine

glucoside.

88

BIBLIOGRAPHY

Allen, G. (1990). Sequencing of proteins and peptides.
Second revised edition. Elsevier: Amsterdam. 87-90.
Bando, M. Nakajima, A. and Satoh, K. (1980).
Spectrophotometric estimation of 3-hydroxykynurenine
glucoside in the human lens. J. Biochem. 89. 103-09.
Berbers, G. A. M., Heokman, W. A., Bleomendal, H, De Jong, W.
W., Kleinschmidt, T. and Braunitzer, G. (1984). Homology
between the primary structures of the major bovine pcrystallin chains. Eur. J. Biochem. 139. 467-75.
Carver, J. A., Aquilina, J. A., Truscott, R. J. W. and Ralston, G.
R. (1992). Identification by 1H-NMR spectroscopy of flexible
C-terminal extensions in bovine lens a-crystallin. FEBS. 311.
143-49.
Carver, J. A., Cooper, P. G. and Truscott, R. J. W. (1993). 1HNMR spectroscopy of pB2-crystallin from bovine eye lens:
confirmation of the N- and C-terminal extensions. Eur. J.
Biochem. 213. 313-320.
Cooper, G. F. and Robson, J. G. (1969). The yellow colour of
the lens of man and other primates. J. Physiol. 203, 411-17.
Cooper, P. G., Carver, J. A. and Truscott, R. J. W. (1993). 1HNMR spectroscopy of bovine lens p-crystallin: The role of the

89

pB 2-cry stallin C-terminal extension in aggregation. Eur. J.
Biochem. 213. 321-28.
Dillon, J. and Atherton, S. J. (1990). Time resolved spectro
scopic studies on the intact human lens. Photochemistry and
Photobiology. 51. 465-68.
Emmons, T. and Takemoto, L. (1992). Age-dependent loss of
the C-terminal amino acid from alpha crystallin. Exp. Eye
Res. 55. 551-54
Ewing, A. G., Wallingford, R. A. and Olefirowicz, T. M. (1989).
Capillary Electrophoresis. Anal. Chem. 61. 292A-302A.
Feigelson, P. and Greengard, O. (1961) A microsomal ironporphyrin activator of rat liver tryptophan pyrrolase. J. Biol.
Chem. 236

153-57.

Fevery, J., Van Hees, G. P., Leroy, P., Compernolle, F. and
Heirwegh, K. P. M.(1971). Excretion in dog bile of glucose and
xylose conjugates of bilirubin. Biochem. J. 125. 803-10.
Furniss, B. S., Hannaford, A. J., Smith, P. W. G. and Tatchell, A.
R. (1989). Vogel's textbook of practical organic chemistry
(fifth edition),

p. 647-48.

Gordon, M. J., Huang, X. H., Pentoney, S. L. and Zare, R. N.
(1988). Capillary electrophoresis. Science. 242. 224-28.
Harding, J. (1991) Cataract: Biochemistry Epidemiology and
pharmacology.

Chapman and Hall: London.

90

Harding, J. and Crabbe, M. J. C. (1976). Structural proteins of
the mammalian lens: a review with emphasis on changes in
development, aging and cataract. Exp. Eye. Res. 22. 1-73.
Hayaishi, O and Okamoto, H. (1971). Localization and some
properties of kynurenine-3-hydroxylase and kynurenine
aminotranferase. Am. J. Clin. Nutr. 24. 805-06.
Hockwin, O. (1971). Altern. Entwickl. 1. 95-129.
Jorgenson, J. and Lukács, K. D. (1981). Anal. Chem. 53. 1298
302.
Kleiman, N. J., Chiesa, R., Kolks, M. A. G. and Spector, A.
(1988). Phosphorylation of p-crystallin B2 (pBp) in the
bovine lens. J. Biol. Chem. 263. 14978-83.
Knox, W. E. and Mehler, A. H. (1950). The conversion of
tryptophan to kynurenine in liver. I. The coupled
tryptophan peroxidase-oxidase system forming
formylkynurenine. J.

Biol. Chem. 187. 419-30.

Kuhr, W. G. and Monnig, C. A. (1992). Capillary
electrophoresis. Anal. Chem. 64. 369R-407R.
Method, (1992). Protein electrospray mass spectrometry.
Today's life science. A pril. 44-52.
Okamoto, H., Yamamoto, S., Nozaki, M. and Hayaishi, O.
(1967). On the submitochondrial localization of kynurenine3-hydroxylase. Biochem. Biophys. Res. commun. 26. 309-14.

91

Thompson, J. A. and Augusteyn, R. C. (1983). a m Crystallin:
the native form of the protein? Exp. Eye. Res. 37. 367-77.
Tsutsumi, H and Ishido, Y. (1981). Synthesis of phenyl Dglucopyranosides; nucleophilic substitution of 0-(2,3,4,6tetra-0-benzyl-D-glucopyranosyl)-pseudoureas

by

phenols.

Carbohydrate Research. 88. 61-75.
Pasaribuet, S. J. and Williams, L. R. (1973). Selective
bromination of substituted acetophenones with dioxan
dibromide. Aust. J. Chem. 26. 1327-31.
Smith, R. D., Loo, J. A., Edmonds, C. G., Barinaga, C. J. and
Udseth, H. R. (1990). New Developments in Biochemical Mass
Spectometry: Electrospray Ionization. Anal Chem. 62. 882
89.
van den Octelaar, P. J. M., Clauwaert, J., van Laehem, J. and
Hoenders, H. J. (1985). The influence of isolation conditions
on the molecular weight of bovine a-crystallin. J. Biol. Chem.
260. 14030-34.
van Heyningen, R. (1971a). Fluorescent glucoside in the
human lens. Nature 230, 393-4.
van Heyningen, R. (1971b). Fluorescent derivatives of 3hydroxykynurenine in the lens of man, the Baboon and the
grey squirrel. Bio chem. J. 123, 30-31.
van Heyningen, R. (1973a). Assay of fluorescent: glucoside in
the human lens. Exp. Eye. Res. 15. 121-26.

92

van Heyningen, R. (1973b). The glucoside of 3-hydroxy kynurenine and other fluorescent compounds in the human
lens. In The human lens in relation to cataract.

CIBA

Foundation Symposium 19. (new series). 151-57. Elsevier:
Amsterdam.
van Heyningen, R. and Waley, S. G. (1963). Natural
proteinases in the lens. 2: partial purification and properties.
Biochem. J. 86. 92-101
Virtanen, R. (1974) Acta Polytech. Scand. 123. 1-67.
Walls, G. L. (1942). The vertebrate eye and its adaptive
Radiation. Reprinted 1963. New York: Haffner.
Wood, A. M. and Truscott, R. J. W. (1993). UV filters in
human lenses: tryptophan catabolism. Exp. Eye. Res. 56.
317-325.
Xu, Y. (1992). Capillary electrophoresis. Anal. Chem. 65.
425R-432R.
Yoshida, H., Yumoto, N., Tsukahara, I. and Murachi, T. (1986).
The degradation of a-crystallin at its carboxyl-terminal
portion by calpain in bovine lens. Invest. Ophthalmol. Vis.
Sci. 27. 1269-73.

